KANSAS CITY, Mo. — 41 Action News is offering a daily recap of COVID-19 related stories from across Kansas City and the country. Check back every morning for the latest developments.
LATEST: COVID-19 case tracker for Missouri, Kansas and Kansas City
University of Kansas Health System daily briefing
Dr. David Wild and registered nurse Lance Williamson joined Dr. Dana Hawkinson to answer viewer questions during Friday's briefing. The hospital currently has 36 active COVID-19 patients in the hospital, with 11 in the ICU and four on the ventilator. There are 33 patients still in recovery as well.
Since the start of the pandemic, the University of Kansas Health System has seen 950 hospitalizations from COVID-19. The average age of patients has been 55, and 30 patients have been juveniles. The youngest patient who died was 21 years old and the oldest was 97.
Grants available in Overland Park, Grandview for small businesses, individuals
Individuals and small businesses in Overland Park and Grandview now have new ways to get financial help as the COVID-19 pandemic continues to disrupt the economic situation for thousands of people.
Both cities are using money sent to them through the CARES Act to set up grant programs. Each city has a program for individuals and a program for small businesses.
KCMO extends outdoor dining ordinance for restaurants
The Kansas City, Missouri, City Council on Thursday voted to extend an ordinance that allows restaurants to move their dining rooms to the sidewalks or, in some cases, block off streets to allow for more dining space and social distancing. The ordinance now lasts through April 19, 2021.
UMKC suspends 3 athletic programs due to COVID-19 financial impacts
The University of Missouri-Kansas City is suspending its golf, cross county and track-and-field programs due to financial strain from COVID-19. The suspension begins Nov. 1 and will result in layoffs and furloughs.
Remdesivir becomes first FDA fully approved coronavirus treatment
The Food and Drug Administration approved remdesivir as a treatment for COVID-19. Some studies differ on whether the drug is actually effective or not, especially in hospitalized patients.
—
Find more coronavirus news and resources from 41 Action News here.
